174 related articles for article (PubMed ID: 16608734)
1. Modified poly(propylene imine) dendrimers as effective transfection agents for catalytic DNA enzymes (DNAzymes).
Tack F; Bakker A; Maes S; Dekeyser N; Bruining M; Elissen-Roman C; Janicot M; Brewster M; Janssen HM; De Waal BF; Fransen PM; Lou X; Meijer EW
J Drug Target; 2006 Feb; 14(2):69-86. PubMed ID: 16608734
[TBL] [Abstract][Full Text] [Related]
2. Dendrimeric poly(propylene-imines) as effective delivery agents for DNAzymes: dendrimer synthesis, stability and oligonucleotide complexation.
Tack F; Bakker A; Maes S; Dekeyser N; Bruining M; Elissen-Roman C; Janicot M; Janssen HM; De Waal BF; Fransen PM; Lou X; Meijer EW; Arien A; Brewster ME
J Control Release; 2006 Nov; 116(2):e24-6. PubMed ID: 17718950
[No Abstract] [Full Text] [Related]
3. Investigations on biodistribution of technetium-99m-labeled carbohydrate-coated poly(propylene imine) dendrimers.
Agashe HB; Babbar AK; Jain S; Sharma RK; Mishra AK; Asthana A; Garg M; Dutta T; Jain NK
Nanomedicine; 2007 Jun; 3(2):120-7. PubMed ID: 17572354
[TBL] [Abstract][Full Text] [Related]
4. Maltose modified poly(propylene imine) dendrimers as potential carriers of nucleoside analog 5'-triphosphates.
Szulc A; Signorelli M; Schiraldi A; Appelhans D; Voit B; Bryszewska M; Klajnert-Maculewicz B; Fessas D
Int J Pharm; 2015 Nov; 495(2):940-7. PubMed ID: 26456295
[TBL] [Abstract][Full Text] [Related]
5. Gene delivery efficiency and cytotoxicity of heterocyclic amine-modified PAMAM and PPI dendrimers.
Hashemi M; Tabatabai SM; Parhiz H; Milanizadeh S; Amel Farzad S; Abnous K; Ramezani M
Mater Sci Eng C Mater Biol Appl; 2016 Apr; 61():791-800. PubMed ID: 26838910
[TBL] [Abstract][Full Text] [Related]
6. Dendrimeric poly(propylene-imines) as effective delivery agents for DNAzymes: toxicity, in vitro transfection and in vivo delivery.
Tack F; Bakker A; Maes S; Dekeyser N; Bruining M; Elissen-Roman C; Janicot M; Janssen HM; De Waal BF; Fransen PM; Lou X; Meijer EW; Arien A; Brewster ME
J Control Release; 2006 Nov; 116(2):e26-8. PubMed ID: 17718951
[No Abstract] [Full Text] [Related]
7. The influence of maltotriose-modified poly(propylene imine) dendrimers on the chronic lymphocytic leukemia cells in vitro: dense shell G4 PPI.
Franiak-Pietryga I; Ziółkowska E; Ziemba B; Appelhans D; Voit B; Szewczyk M; Góra-Tybor J; Robak T; Klajnert B; Bryszewska M
Mol Pharm; 2013 Jun; 10(6):2490-501. PubMed ID: 23641871
[TBL] [Abstract][Full Text] [Related]
8. Genotoxicity of poly(propylene imine) dendrimers.
Ziemba B; Matuszko G; Appelhans D; Voit B; Bryszewska M; Klajnert B
Biopolymers; 2012 Aug; 97(8):642-8. PubMed ID: 22605555
[TBL] [Abstract][Full Text] [Related]
9. Polypropyleneimine and polyamidoamine dendrimer mediated enhanced solubilization of bortezomib: Comparison and evaluation of mechanistic aspects by thermodynamics and molecular simulations.
Chaudhary S; Gothwal A; Khan I; Srivastava S; Malik R; Gupta U
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():611-619. PubMed ID: 28024628
[TBL] [Abstract][Full Text] [Related]
10. Toxicity and proapoptotic activity of poly(propylene imine) glycodendrimers in vitro: considering their contrary potential as biocompatible entity and drug molecule in cancer.
Ziemba B; Franiak-Pietryga I; Pion M; Appelhans D; Muñoz-Fernández MÁ; Voit B; Bryszewska M; Klajnert-Maculewicz B
Int J Pharm; 2014 Jan; 461(1-2):391-402. PubMed ID: 24361266
[TBL] [Abstract][Full Text] [Related]
11. Comparison of generation 3 polyamidoamine dendrimer and generation 4 polypropylenimine dendrimer on drug loading, complex structure, release behavior, and cytotoxicity.
Shao N; Su Y; Hu J; Zhang J; Zhang H; Cheng Y
Int J Nanomedicine; 2011; 6():3361-72. PubMed ID: 22267921
[TBL] [Abstract][Full Text] [Related]
12. Studying complexes between PPI dendrimers and Mant-ATP.
Szulc A; Appelhans D; Voit B; Bryszewska M; Klajnert B
J Fluoresc; 2013 Mar; 23(2):349-56. PubMed ID: 23306952
[TBL] [Abstract][Full Text] [Related]
13. The influence of maltose modified poly(propylene imine) dendrimers on hen egg white lysozyme structure and thermal stability.
Ciolkowski M; Pałecz B; Appelhans D; Voit B; Klajnert B; Bryszewska M
Colloids Surf B Biointerfaces; 2012 Jun; 95():103-8. PubMed ID: 22410344
[TBL] [Abstract][Full Text] [Related]
14. Poly(propylene imine) dendrimers modified with maltose or maltotriose protect phosphorothioate oligodeoxynucleotides against nuclease activity.
Drzewińska J; Appelhans D; Voit B; Bryszewska M; Klajnert B
Biochem Biophys Res Commun; 2012 Oct; 427(1):197-201. PubMed ID: 22995301
[TBL] [Abstract][Full Text] [Related]
15. Inclusion complexes of isoflavones with two commercially available dendrimers: Solubility, stability, structures, release behaviors, cytotoxicity, and anti-oxidant activities.
Zhao C; Wang Y; Su Y; Zhang H; Ding L; Yan X; Zhao D; Shao N; Ye X; Cheng Y
Int J Pharm; 2011 Dec; 421(2):301-9. PubMed ID: 22001794
[TBL] [Abstract][Full Text] [Related]
16. Maltotriose-modified poly(propylene imine) Glycodendrimers as a potential novel platform in the treatment of chronic lymphocytic Leukemia. A proof-of-concept pilot study in the animal model of CLL.
Franiak-Pietryga I; Ziemba B; Sikorska H; Jander M; Kuncman W; Danilewicz M; Appelhans D; Lewkowicz P; Ostrowska K; Bryszewska M; Borowiec M
Toxicol Appl Pharmacol; 2020 Sep; 403():115139. PubMed ID: 32687837
[TBL] [Abstract][Full Text] [Related]
17. Formulation development and in vitro-in vivo assessment of the fourth-generation PPI dendrimer as a cancer-targeting vector.
Kesharwani P; Tekade RK; Jain NK
Nanomedicine (Lond); 2014 Oct; 9(15):2291-308. PubMed ID: 24593000
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and characterization of guanidinylated poly(propylene imine) dendrimers as gene transfection agents.
Tziveleka LA; Psarra AM; Tsiourvas D; Paleos CM
J Control Release; 2007 Jan; 117(1):137-46. PubMed ID: 17156881
[TBL] [Abstract][Full Text] [Related]
19. Interaction study between maltose-modified PPI dendrimers and lipidic model membranes.
Wrobel D; Appelhans D; Signorelli M; Wiesner B; Fessas D; Scheler U; Voit B; Maly J
Biochim Biophys Acta; 2015 Jul; 1848(7):1490-501. PubMed ID: 25843678
[TBL] [Abstract][Full Text] [Related]
20. Ligand anchored dendrimers based nanoconstructs for effective targeting to cancer cells.
Gupta U; Dwivedi SK; Bid HK; Konwar R; Jain NK
Int J Pharm; 2010 Jun; 393(1-2):185-96. PubMed ID: 20382210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
